These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38473739)
1. Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models. Avitabile E; Menotti L; Giordani B; Croatti V; Parolin C; Vitali B Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473739 [TBL] [Abstract][Full Text] [Related]
2. Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2. Kassaa IA; Hober D; Hamze M; Caloone D; Dewilde A; Chihib NE; Drider D Arch Microbiol; 2015 Jun; 197(5):657-64. PubMed ID: 25752765 [TBL] [Abstract][Full Text] [Related]
3. Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines. Mousavi E; Makvandi M; Teimoori A; Ataei A; Ghafari S; Samarbaf-Zadeh A J Chin Med Assoc; 2018 Mar; 81(3):262-267. PubMed ID: 29037754 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. Conti C; Malacrino C; Mastromarino P J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():19-26. PubMed ID: 20224147 [TBL] [Abstract][Full Text] [Related]
5. Vaginal Lactobacilli Reduce Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390 [TBL] [Abstract][Full Text] [Related]
6. Isolation of Vaginal Lactobacilli and Characterization of Anti-Candida Activity. Parolin C; Marangoni A; Laghi L; Foschi C; Ñahui Palomino RA; Calonghi N; Cevenini R; Vitali B PLoS One; 2015; 10(6):e0131220. PubMed ID: 26098675 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens. Scillato M; Spitale A; Mongelli G; Privitera GF; Mangano K; Cianci A; Stefani S; Santagati M Microbiologyopen; 2021 Feb; 10(2):e1173. PubMed ID: 33970542 [TBL] [Abstract][Full Text] [Related]
8. Exopolysaccharides from vaginal lactobacilli modulate microbial biofilms. Giordani B; Naldi M; Croatti V; Parolin C; Erdoğan Ü; Bartolini M; Vitali B Microb Cell Fact; 2023 Mar; 22(1):45. PubMed ID: 36890519 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo. Zabihollahi R; Motevaseli E; Sadat SM; Azizi-Saraji AR; Asaadi-Dalaie S; Modarressi MH Daru; 2012 Oct; 20(1):53. PubMed ID: 23351891 [TBL] [Abstract][Full Text] [Related]
10. Lactobacilli extracellular vesicles: potential postbiotics to support the vaginal microbiota homeostasis. Croatti V; Parolin C; Giordani B; Foschi C; Fedi S; Vitali B Microb Cell Fact; 2022 Nov; 21(1):237. PubMed ID: 36376912 [TBL] [Abstract][Full Text] [Related]
11. Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections. Avitabile E; Menotti L; Croatti V; Giordani B; Parolin C; Vitali B Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273118 [TBL] [Abstract][Full Text] [Related]
12. Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate. Motevaseli E; Shirzad M; Akrami SM; Mousavi AS; Mirsalehian A; Modarressi MH J Med Microbiol; 2013 Jul; 62(Pt 7):1065-1072. PubMed ID: 23618799 [TBL] [Abstract][Full Text] [Related]
13. Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. Chee WJY; Chew SY; Than LTL Microb Cell Fact; 2020 Nov; 19(1):203. PubMed ID: 33160356 [TBL] [Abstract][Full Text] [Related]
14. Identification and characterisation of vaginal lactobacilli from South African women. Pendharkar S; Magopane T; Larsson PG; de Bruyn G; Gray GE; Hammarström L; Marcotte H BMC Infect Dis; 2013 Jan; 13():43. PubMed ID: 23351177 [TBL] [Abstract][Full Text] [Related]
15. In-vitro effect of vaginal lactobacilli against group B Streptococcus. Marziali G; Foschi C; Parolin C; Vitali B; Marangoni A Microb Pathog; 2019 Nov; 136():103692. PubMed ID: 31445119 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study. Vicariotto F; Mogna L; Del Piano M J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116 [TBL] [Abstract][Full Text] [Related]
17. Vaginal Lactobacilli Induce Differentiation of Monocytic Precursors Toward Langerhans-like Cells: Song J; Lang F; Zhao N; Guo Y; Zhang H Front Immunol; 2018; 9():2437. PubMed ID: 30410487 [TBL] [Abstract][Full Text] [Related]
18. Determination of Antibacterial and Technological Properties of Vaginal Lactobacilli for Their Potential Application in Dairy Products. Siroli L; Patrignani F; Serrazanetti DI; Parolin C; Ñahui Palomino RA; Vitali B; Lanciotti R Front Microbiol; 2017; 8():166. PubMed ID: 28223974 [TBL] [Abstract][Full Text] [Related]
19. Effects of vaginal lactobacilli in Chlamydia trachomatis infection. Mastromarino P; Di Pietro M; Schiavoni G; Nardis C; Gentile M; Sessa R Int J Med Microbiol; 2014 Jul; 304(5-6):654-61. PubMed ID: 24875405 [TBL] [Abstract][Full Text] [Related]